Associated Papers
Molecular heterogeneity and measurable residual disease of rare NPM1 mutations in acute myeloid leukemia: a nationwide experience from the GBMHM study group.
Fournier E et al.
Leukemia, 2022
Networking for advanced molecular diagnosis in acute myeloid leukemia patients is possible: the PETHEMA NGS-AML project
Sargas C et al.
Haematologica, 2021
33179471 (PubMed )
Supplement: 2020_263806_SARGAS_SUPPL.pdf
Next-generation sequencing reveals clinically actionable molecular markers in myeloid sarcoma.
Li Z et al.
Leukemia, 2015
Quantification of rare NPM1 mutation subtypes by digital PCR.
Bacher U et al.
British Journal of Haematology, 2014
Select a paper to view details